{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:19:40Z","timestamp":1761157180105,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014088","name":"AstraZeneca France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.numecd.2021.06.017","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:37:19Z","timestamp":1625099839000},"page":"2945-2958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose tolerance: A placebo-controlled study"],"prefix":"10.1016","volume":"31","author":[{"given":"Amel","family":"Rezki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Cosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinos","family":"Fysekidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vicaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.06.017_bib1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1016\/j.numecd.2021.06.017_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1262-3636(06)70484-0","article-title":"Hemodynamic changes in postprandial state","volume":"32","author":"Valensi","year":"2006","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.numecd.2021.06.017_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Decode Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria","volume":"161","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib5","doi-asserted-by":"crossref","first-page":"107947","DOI":"10.1016\/j.diabres.2019.107947","article-title":"CVOTs: what did the endocrinologist learn ?","volume":"159","author":"Valensi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2021.06.017_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.cellsig.2013.05.009","article-title":"Cardiovascular pleiotropic actions of DPP-4 inhibitors: a step at the cutting edge in understanding their additional therapeutic potentials","volume":"25","author":"Balakumar","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.numecd.2021.06.017_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/VHRM.S75215","article-title":"Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease","volume":"11","author":"Toth","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.numecd.2021.06.017_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.beem.2009.03.004","article-title":"Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)","volume":"23","author":"Thornberry","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"9548","key":"10.1016\/j.numecd.2021.06.017_bib9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2021.06.017_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrcardio.2012.183","article-title":"Cardiovascular effects of gliptins","volume":"10","author":"Scheen","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2021.06.017_bib11","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.2337\/dc14-0865","article-title":"The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications","volume":"37","author":"Avogaro","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.06.017_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vph.2018.05.010","article-title":"Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases","volume":"109","author":"Xie","year":"2018","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2021.06.017_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1479164116629352","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: a pilot study","volume":"13","author":"Leung","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.numecd.2021.06.017_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-016-0493-3","article-title":"A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes","volume":"16","author":"Jax","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2021.06.017_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12933-017-0595-6","article-title":"Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin","volume":"16","author":"Pollack","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2021.06.017_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0091270008316885","article-title":"Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension","volume":"48","author":"Mistry","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.numecd.2021.06.017_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31826be204","article-title":"Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats","volume":"60","author":"Mason","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.numecd.2021.06.017_bib18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.numecd.2020.12.025","article-title":"Acute and long-term effects of saxagliptin on post-prandial glycemic response in obese patients with impaired glucose tolerance","volume":"31","author":"Rezki","year":"2021","journal-title":"Nutr Metabol Cardiovasc Dis"},{"year":"1999","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus","author":"WHO","key":"10.1016\/j.numecd.2021.06.017_bib20"},{"key":"10.1016\/j.numecd.2021.06.017_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/pst.185","article-title":"Sample size of 12 per group rule of thumb for a pilot study","volume":"4","author":"Julious","year":"2005","journal-title":"Pharmaceut Stat"},{"key":"10.1016\/j.numecd.2021.06.017_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mvr.2017.09.005","article-title":"Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients","volume":"116","author":"Fysekidis","year":"2018","journal-title":"Microvasc Res"},{"key":"10.1016\/j.numecd.2021.06.017_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/VHRM.S215795","article-title":"Association between adherence to the French dietary guidelines and lower resting heart rate, longer diastole duration, and lower myocardial oxygen consumption. The NUTRIVASC Study","volume":"15","author":"Fysekidis","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.numecd.2021.06.017_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00380-018-1118-4","article-title":"Endothelial function estimated by digital reactive hyperemia in patients with atherosclerotic risk factors or coronary artery disease","volume":"33","author":"Kang","year":"2018","journal-title":"Heart Ves"},{"key":"10.1016\/j.numecd.2021.06.017_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.numecd.2015.08.001","article-title":"Arterial stiffness is elevated in normotensive type 2 diabetic patients with peripheral neuropathy","volume":"25","author":"Chen","year":"2015","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2021.06.017_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1358863X07081134","article-title":"Indices of cardiovascular function derived from peripheral pulse wave analysis using radial applanation tonometry: a measurement repeatability study","volume":"12","author":"Crilly","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1440-1681.2008.04927.x","article-title":"Subendocardial viability ratio estimated by arterial tonometry: a critical evaluation in elderly hypertensive patients with increased aortic stiffness","volume":"35","author":"Chemla","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.numecd.2021.06.017_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1109\/10.341836","article-title":"An advanced signal processing technique for impedance cardiography","volume":"42","author":"Wang","year":"1995","journal-title":"EEE Trans Biomed Eng"},{"key":"10.1016\/j.numecd.2021.06.017_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4037\/ajcc2004.13.6.469","article-title":"Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure","volume":"13","author":"Albert","year":"2004","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.numecd.2021.06.017_bib30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/dmrr.1224","article-title":"Investigation methods for cardiac autonomic function in human research studies","volume":"27","author":"Bernardi","year":"2011","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.numecd.2021.06.017_bib31","first-page":"944","article-title":"Arterial rigidity and cardiovascular vagosympathetic activity in normotensive and hypertensive obese patients and type 2 diabetics","volume":"94","author":"Brahimi","year":"2001","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.numecd.2021.06.017_bib32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.5551\/jat.7666","article-title":"Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats","volume":"18","author":"Mason","year":"2011","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.numecd.2021.06.017_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-018-0716-x","article-title":"Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial","volume":"17","author":"Tripolt","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2021.06.017_bib34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment","volume":"106","author":"Ceriello","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.06.017_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/ajcn\/78.3.454","article-title":"Effect of orange juice intake on vitamin C concentrations and biomarkers of antioxidant status in humans","volume":"78","author":"Sanchez-Moreno","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.06.017_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3945\/ajcn.111.031088","article-title":"Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk","volume":"95","author":"Buscemi","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.06.017_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1479164114533355","article-title":"The DPP-4 inhibitor sitagliptin and endothelial function in patients with acute coronary syndromes and newly detected glucose perturbations: a report from the BEGAMI study","volume":"11","author":"Hage","year":"2014","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.numecd.2021.06.017_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/bc.2011.002","article-title":"Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries","volume":"392","author":"Matheeussen","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.numecd.2021.06.017_bib39","first-page":"113","article-title":"Cardiac autonomic function in obese patients","volume":"19","author":"Valensi","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.numecd.2021.06.017_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1464-5491.2011.03278.x","article-title":"Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance","volume":"28","author":"Laitinen","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0035-1569264","article-title":"Are obese individuals with no feature of metabolic syndrome but increased waist circumference really healthy? A cross sectional study","volume":"124","author":"Chiheb","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.numecd.2021.06.017_bib42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-5491.2010.03027.x","article-title":"Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications","volume":"27","author":"Ayad","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2021.06.017_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ancard.2015.04.021","article-title":"Relationship between blood pressure, heart rate and cardiac autonomic dysfunction in non-diabetic obese patients","volume":"64","author":"Banu","year":"2015","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.numecd.2021.06.017_bib44","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diacare.29.04.06.dc05-1729","article-title":"The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program","volume":"29","author":"Carnethon","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.06.017_bib45","doi-asserted-by":"crossref","first-page":"R874","DOI":"10.1152\/ajpregu.00153.2008","article-title":"Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans","volume":"295","author":"Bharucha","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.numecd.2021.06.017_bib46","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00125-013-2848-6","article-title":"Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control","volume":"56","author":"Berkelaar","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.06.017_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00125-013-2909-x","article-title":"Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter","volume":"56","author":"Valensi","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2021.06.017_bib48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2016.07.009","article-title":"Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: potential impact of dipeptidyl peptidase-4 inhibitors","volume":"167","author":"Anderluh","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.numecd.2021.06.017_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002081","article-title":"Dipeptidyl peptidase 4 inhibition alleviates shortage of circulating glucagon-like peptide-1 in heart failure and mitigates myocardial remodeling and apoptosis via the exchange protein directly activated by cyclic AMP 1\/ras-related protein 1 Axis","volume":"9","author":"Aoyama","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2021.06.017_bib50","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.111.188086","article-title":"Central actions of the chemokine stromal cell-derived factor 1 contribute to neurohumoral excitation in heart failure rats","volume":"59","author":"Wei","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2021.06.017_bib51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/hh1701.095716","article-title":"Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes","volume":"89","author":"Vila Petroff","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2021.06.017_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00380-014-0509-4","article-title":"Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients","volume":"30","author":"Fujiwara","year":"2015","journal-title":"Heart Ves"},{"key":"10.1016\/j.numecd.2021.06.017_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1475-2840-13-33","article-title":"Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials","volume":"13","author":"Iqbal","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2021.06.017_bib54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-016-0472-8","article-title":"Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study","volume":"15","author":"Tomiyama","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2021.06.017_bib55","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1570161114666160625090212","article-title":"Anagliptin, A dipeptidyl peptidase-4 inhibitor ameliorates arterial stiffness in association with reduction of remnant-like particle cholesterol and alanine transaminase levels in type 2 diabetic patients","volume":"14","author":"Tahara","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2021.06.017_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vph.2011.03.001","article-title":"Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways","volume":"55","author":"Shah","year":"2011","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.numecd.2021.06.017_bib57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/cs1020523","article-title":"Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans","volume":"102","author":"Scott","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.numecd.2021.06.017_bib58","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1210\/jc.2010-0413","article-title":"The effect of a high-fat meal on postprandial arterial stiffness in men with obesity and type 2 diabetes","volume":"95","author":"Phillips","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2021.06.017_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajh\/hpt211","article-title":"Acute effects of a mixed meal on arterial stiffness and central hemodynamics in healthy adults","volume":"27","author":"Taylor","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2021.06.017_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCULATIONAHA.104.495127","article-title":"Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients","volume":"112","author":"Scognamiglio","year":"2005","journal-title":"Circulation"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:17:10Z","timestamp":1760545030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0939475321002945"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.06.017","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose tolerance: A placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}